logo

Production has started

TELTOHEART 
 

First-ever multifunctional smart wristband for medical purposes with an exceptional set of features and design which allows user to record 6-lead¹ ECG and detects atrial fibrillation or other arrhythmias with MyHealth app².

teltoheart.png

SMART MEDICAL WRISTBAND WITH 

6-LEAD ECG RECORDING²

High precision, medical-grade electrocardiogram recording for your physician to analyse.


ATRIAL FIBRILLATION DETECTION

Patented high specificity algorithm for real time heart arrythmia detection³.


CONTINUOUS HEART RATE MONITORING

A photoplethysmography (PPG) based continuous heart rate measurements.


FIRST EVER SMART MEDICAL WRISTBAND WITH 6-LEAD ECG⁴

first-ever-watch-with-6-lead-ecg.png

What is 6-lead ECG?

Six leads mean that smart wristband with a help of compatible application records 6⁵ medical grade graphics giving data about cardiac activity. A six-lead ECG provides physicians with information about heart condition, giving the ability to detect arrhythmias⁶.

Leads count

In-Hospital ECG

12 leads

TeltoHeart 

6 leads

Non-Wearable Competitors

6 leads

Other Wearable Competitors

1 lead

atrial-afibrillatio.png

WHY ATRIAL FIBRILLATION (AF) MATTERS?

Stroke⁷ is one of the most likely outcomes of atrial fibrillation (AF). In-hospital ECG may not display AF if no symptoms occur during the testing. Atrial Fibrillation remains most clinically significant arrhythmia. Prevalence is about 1-3% in general population which is around 200 million people worldwide⁸.

CUSTOMIZATION

CHOOSE YouR STYLE

Different styles of telto one watch

Still wondering if TELTOHEART fits your needs?

CONTINUOUS HEART RATE MONITORING

watch-landing-page.png

HEART RATE MONITORING, ALL DAY LONG

Our smart medical wristband has an integrated photoplethysmography (PPG) monitoring system that can optically obtain a plethysmogram to detect any chages in blood circulation in a real time manner.

Still wondering if TELTOHEART fits your needs?

Innovation
group-1415.png

TeltoHeart is the first wearable system worldwide combining PPG-based AF detection algorithm for screening of AF together with an instant 6-lead ECG with no wires for rhythm confirmation.

Continuous PPG-based monitoring
group-1422.png

About one-third of AF patients experience asymptomatic episodes, which equally account for serous thromboembolic risk as symptomatic ones and could be undetected if screened only intermittently. The wearable device TeltoHeart provides continuous photoplethysmography (PPG)-based rhythm monitoring, enabling the detection of asymptomatic AF episodes as short as 30 seconds. The capability ensures that even brief, rare and asymptomatic AF episodes are not missed, contributing to early-stage diagnosis and timely intervention.

Enhanced AF Detection Accuracy
th3.jpg

TeltoHeart offers a highly accurate PPG-based algorithm for continuous AF detection, with a sensitivity of 94.2% and specificity of 96.9% when compared to a control group of not only stable sinus rhythm (SR) but also SR with frequent premature contractions. This level of accuracy is essential for the peace of mind of our patients and correct notification to record ECG for rhythm confirmation.

Reduction of false-positives with six-lead ECG
teltoheart2.png

The number of premature beats per minute is the main factor associated with false positive detections in the real-world use of wearables. The widespread use of common single-lead ECGs recorded by other smartwatches or handheld devices significantly increases the risk of false-positive detection in populations with frequent premature contractions. The use of a distinguished six-lead ECG feature required 3.4 times more premature beats to result in a false positive outcome compared to single-lead ECG. Thus, TeltoHeart is a robust tool able to maintain a high specificity despite the challenge posed by ectopic beats.

Patient-Centered Monitoring
th-5.jpg

TeltoHeart non-invasive and unobtrusive design allows patients to be continuously monitored for AF and related arrhythmias without disrupting their daily activities. This patient-centered approach promotes early detection and management, reducing the risk of complications and promoting self- care and motivation to improve health.

Promotion of Health Equity
th-6.jpg

Due to life in rural areas and various socio-economic reasons not every patient has equal access to healthcare services. Wearable technologies like this wrist-worn TeltoHeart have the potential to bridge healthcare gaps in remote areas, enabling access to accurate cardiac monitoring and timely intervention for individuals who may not have easy access to medical facilities.

voice-communicatio.png
th1jpe.jpg

WATER RESISTANT

water-resistant.png

TELTOCARE PLATFORM

teltocare-1.png

Become a Partner

Why you should trust us?
40K+

Global clients that already trust us.

150+

Countries that we are operating in.

25 years

Producing innovative technology solutions.

23M+

Devices produced by Teltonika already deployed worldwide.

Features
Downloads

STAY TUNED!

Subscribe to our newsletter and get latest TELTOHEART updates.

Contact

us